Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 16 | 2025 | 29 | 3.940 |
Why?
|
| Female | 50 | 2025 | 966 | 2.740 |
Why?
|
| Male | 44 | 2025 | 1036 | 2.570 |
Why?
|
| Obesity | 9 | 2020 | 23 | 2.540 |
Why?
|
| Aged | 40 | 2025 | 414 | 2.470 |
Why?
|
| Humans | 60 | 2025 | 1883 | 2.470 |
Why?
|
| Life Expectancy | 8 | 2020 | 8 | 2.170 |
Why?
|
| Alzheimer Disease | 5 | 2025 | 80 | 2.130 |
Why?
|
| Body Mass Index | 12 | 2024 | 35 | 1.990 |
Why?
|
| Prospective Studies | 27 | 2025 | 118 | 1.970 |
Why?
|
| Risk Factors | 27 | 2025 | 140 | 1.770 |
Why?
|
| Cognitive Dysfunction | 9 | 2025 | 53 | 1.750 |
Why?
|
| Healthy Lifestyle | 6 | 2024 | 7 | 1.700 |
Why?
|
| Middle Aged | 29 | 2024 | 488 | 1.680 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 17 | 1.520 |
Why?
|
| Exercise | 10 | 2020 | 19 | 1.450 |
Why?
|
| Netherlands | 18 | 2024 | 19 | 1.300 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 3 | 1.140 |
Why?
|
| Aged, 80 and over | 18 | 2025 | 209 | 1.140 |
Why?
|
| Mothers | 2 | 2018 | 17 | 1.120 |
Why?
|
| Dementia | 5 | 2024 | 31 | 0.880 |
Why?
|
| Risk Assessment | 7 | 2024 | 36 | 0.860 |
Why?
|
| Waist Circumference | 4 | 2016 | 5 | 0.850 |
Why?
|
| DNA Methylation | 6 | 2021 | 22 | 0.840 |
Why?
|
| Neurodegenerative Diseases | 4 | 2025 | 16 | 0.760 |
Why?
|
| Blood Pressure | 3 | 2024 | 16 | 0.750 |
Why?
|
| Menopause | 5 | 2024 | 6 | 0.720 |
Why?
|
| Cohort Studies | 11 | 2025 | 107 | 0.700 |
Why?
|
| Epigenomics | 4 | 2021 | 4 | 0.690 |
Why?
|
| Apolipoprotein E4 | 3 | 2025 | 23 | 0.670 |
Why?
|
| Diet, Mediterranean | 3 | 2024 | 5 | 0.620 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 3 | 0.610 |
Why?
|
| Mortality | 2 | 2016 | 5 | 0.600 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.580 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 69 | 0.580 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 8 | 0.580 |
Why?
|
| Patient Compliance | 1 | 2018 | 8 | 0.580 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.570 |
Why?
|
| Overweight | 4 | 2020 | 9 | 0.560 |
Why?
|
| Adult | 10 | 2024 | 549 | 0.550 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 19 | 0.540 |
Why?
|
| Lipids | 3 | 2025 | 9 | 0.540 |
Why?
|
| Cognition | 4 | 2024 | 73 | 0.520 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 4 | 0.510 |
Why?
|
| tau Proteins | 3 | 2025 | 8 | 0.510 |
Why?
|
| Chicago | 9 | 2025 | 56 | 0.500 |
Why?
|
| United States | 6 | 2024 | 155 | 0.500 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.500 |
Why?
|
| Body Composition | 1 | 2016 | 4 | 0.490 |
Why?
|
| Incidence | 7 | 2025 | 45 | 0.480 |
Why?
|
| Aging | 4 | 2025 | 75 | 0.480 |
Why?
|
| Longitudinal Studies | 6 | 2025 | 80 | 0.480 |
Why?
|
| Anthropometry | 1 | 2015 | 7 | 0.470 |
Why?
|
| Somatotypes | 1 | 2014 | 1 | 0.450 |
Why?
|
| Dietary Approaches To Stop Hypertension | 2 | 2024 | 2 | 0.430 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 19 | 0.410 |
Why?
|
| Postmenopause | 3 | 2018 | 4 | 0.380 |
Why?
|
| Adolescent | 4 | 2024 | 184 | 0.380 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 5 | 0.370 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 3 | 0.370 |
Why?
|
| Environmental Exposure | 2 | 2024 | 2 | 0.370 |
Why?
|
| Atherosclerosis | 3 | 2022 | 3 | 0.360 |
Why?
|
| Air Pollution | 2 | 2024 | 2 | 0.360 |
Why?
|
| CpG Islands | 4 | 2021 | 5 | 0.360 |
Why?
|
| Biomarkers | 5 | 2025 | 51 | 0.340 |
Why?
|
| Child | 3 | 2024 | 154 | 0.330 |
Why?
|
| Brain | 2 | 2024 | 92 | 0.320 |
Why?
|
| Coronary Disease | 2 | 2018 | 5 | 0.290 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 5 | 0.280 |
Why?
|
| Stroke | 3 | 2018 | 31 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 5 | 0.270 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 6 | 0.260 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 2 | 0.250 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 10 | 0.240 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 3 | 0.230 |
Why?
|
| Social Isolation | 1 | 2025 | 2 | 0.230 |
Why?
|
| Loneliness | 1 | 2025 | 7 | 0.230 |
Why?
|
| Air Pollutants | 1 | 2024 | 1 | 0.230 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 1 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2024 | 1 | 0.230 |
Why?
|
| Coffee | 1 | 2024 | 1 | 0.230 |
Why?
|
| Beverages | 1 | 2024 | 3 | 0.230 |
Why?
|
| Memory Disorders | 1 | 2024 | 14 | 0.220 |
Why?
|
| Weight Gain | 3 | 2024 | 4 | 0.220 |
Why?
|
| Surveys and Questionnaires | 3 | 2024 | 95 | 0.220 |
Why?
|
| Sex Factors | 4 | 2019 | 42 | 0.220 |
Why?
|
| Dietary Fats | 1 | 2024 | 7 | 0.210 |
Why?
|
| Alleles | 1 | 2024 | 27 | 0.210 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 10 | 0.210 |
Why?
|
| Alcohol Drinking | 3 | 2020 | 6 | 0.200 |
Why?
|
| Time Factors | 6 | 2019 | 143 | 0.200 |
Why?
|
| Smoking | 3 | 2020 | 28 | 0.200 |
Why?
|
| Neoplasms | 2 | 2020 | 13 | 0.190 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 1 | 0.190 |
Why?
|
| Life Style | 2 | 2022 | 5 | 0.190 |
Why?
|
| Cognition Disorders | 1 | 2022 | 60 | 0.180 |
Why?
|
| Weight Loss | 2 | 2020 | 8 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 4 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 41 | 0.180 |
Why?
|
| Leukocytes | 1 | 2021 | 1 | 0.180 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 2 | 0.180 |
Why?
|
| Phenotype | 2 | 2018 | 50 | 0.180 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 6 | 0.180 |
Why?
|
| Body Weight | 2 | 2018 | 13 | 0.180 |
Why?
|
| Dyslipidemias | 2 | 2019 | 2 | 0.170 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 16 | 0.160 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 2 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 4 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 3 | 0.150 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 2 | 0.150 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 1 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2017 | 2 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 10 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2018 | 3 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 3 | 0.140 |
Why?
|
| Child Behavior | 1 | 2018 | 5 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 11 | 0.140 |
Why?
|
| Androgens | 1 | 2018 | 1 | 0.140 |
Why?
|
| Testosterone | 1 | 2018 | 1 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2018 | 1 | 0.140 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.140 |
Why?
|
| Diet, Reducing | 1 | 2018 | 2 | 0.140 |
Why?
|
| Basal Metabolism | 1 | 2018 | 2 | 0.140 |
Why?
|
| Pregnancy | 1 | 2018 | 44 | 0.140 |
Why?
|
| Nitrates | 1 | 2017 | 1 | 0.140 |
Why?
|
| Thiocyanates | 1 | 2017 | 1 | 0.140 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.140 |
Why?
|
| Child, Preschool | 1 | 2018 | 87 | 0.140 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 1 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2017 | 43 | 0.140 |
Why?
|
| Vascular Calcification | 1 | 2017 | 1 | 0.140 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 1 | 0.130 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 1 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2017 | 1 | 0.130 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.130 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.130 |
Why?
|
| Protective Factors | 4 | 2018 | 6 | 0.130 |
Why?
|
| Histones | 1 | 2016 | 2 | 0.130 |
Why?
|
| Transportation | 1 | 2016 | 1 | 0.130 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 1 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 1 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 7 | 0.130 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 16 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 1 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 1 | 0.130 |
Why?
|
| Health Behavior | 1 | 2016 | 11 | 0.120 |
Why?
|
| Comorbidity | 1 | 2016 | 27 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2016 | 4 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 6 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 1 | 0.120 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 2 | 0.120 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 1 | 0.120 |
Why?
|
| Body Size | 1 | 2015 | 2 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 6 | 0.120 |
Why?
|
| Prognosis | 1 | 2015 | 28 | 0.120 |
Why?
|
| Independent Living | 2 | 2025 | 11 | 0.120 |
Why?
|
| Sweating | 1 | 2014 | 1 | 0.110 |
Why?
|
| Hot Flashes | 1 | 2014 | 1 | 0.110 |
Why?
|
| Perimenopause | 1 | 2014 | 1 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 36 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 48 | 0.110 |
Why?
|
| Diet | 2 | 2024 | 21 | 0.110 |
Why?
|
| Risk | 3 | 2018 | 23 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 14 | 0.100 |
Why?
|
| Genotype | 2 | 2024 | 37 | 0.090 |
Why?
|
| Triglycerides | 2 | 2025 | 7 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 10 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 4 | 0.080 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 2 | 0.070 |
Why?
|
| Prevalence | 2 | 2018 | 26 | 0.070 |
Why?
|
| Age Factors | 2 | 2017 | 51 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 41 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 63 | 0.060 |
Why?
|
| Heterozygote | 1 | 2025 | 22 | 0.060 |
Why?
|
| Switzerland | 1 | 2024 | 1 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 3 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 1 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 1 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 4 | 0.060 |
Why?
|
| Copper | 1 | 2024 | 6 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 1 | 0.060 |
Why?
|
| Hypertension | 1 | 2024 | 10 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2024 | 12 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 1 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 1 | 0.060 |
Why?
|
| Energy Intake | 1 | 2024 | 8 | 0.060 |
Why?
|
| Animals | 2 | 2016 | 728 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 1 | 0.050 |
Why?
|
| Gene Expression | 1 | 2022 | 27 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 1 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 6 | 0.050 |
Why?
|
| Music Therapy | 1 | 2020 | 1 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 1 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 3 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 13 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 10 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 12 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 9 | 0.040 |
Why?
|
| Educational Status | 1 | 2019 | 22 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 1 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 1 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 19 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2018 | 7 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 22 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2018 | 9 | 0.040 |
Why?
|
| Health Status | 1 | 2018 | 12 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 1 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 1 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 5 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 2 | 0.030 |
Why?
|
| Life Tables | 1 | 2017 | 1 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 27 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 1 | 0.030 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.030 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 1 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 4 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 19 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 16 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 14 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 69 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 1 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 27 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 8 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 1 | 0.030 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 3 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 16 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 4 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 10 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 10 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 3 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 189 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 23 | 0.030 |
Why?
|
| Health | 1 | 2016 | 1 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 11 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 1 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 2 | 0.030 |
Why?
|
| Walking | 1 | 2016 | 6 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2016 | 42 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 17 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 4 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 10 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 19 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 10 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 15 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 71 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 1 | 0.030 |
Why?
|